Skip to main content
. 2018 Oct 12;19(10):3127. doi: 10.3390/ijms19103127

Figure 2.

Figure 2

Emodin did not sensitize HCC to the anti-cancer effect of doxorubicin or 5-fluorouracil. (A) The viability of three HCC cell lines after treatment with of emodin and doxorubicin. (B) The combinatory anti-cancer effect of emodin and 5-fluorouracil in the HCC cell lines. Cells were treated with the indicated drugs (1 μM doxorubicin or 10 μM 5-fluorouracil) for 48 h in the absence or presence of 20 μM emodin. The values are presented as the mean ± SEM of three independent experiments performed in duplicate; * p < 0.05 and ** p < 0.01.